Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Horm Metab Res ; 42(4): 230-6, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20119884

RESUMEN

The effects of estrogen on phosphate metabolism are not well understood. To better define the chronic effects of estrogen on phosphate balance and on renal phosphate handling, the following groups were examined: A. young male and female rats, age- and weight-matched (age 8-10 weeks, 1 (st) study), and B. ovariectomized female rats (OVX), 22 weeks old, ovariectomized aged-matched rats receiving estrogen replacement (15 micromol x 3/week) for 14 weeks (OVX+E), control female rats (intact ovaries), and male rats, both age matched to OVX and OVX+E (2 (nd) Study). In younger females (1 (st) study), plasma phosphate was lower, whereas the urinary excretion of phosphate was higher than in males. In adult intact females and in OVX+E urinary excretion of phosphate was higher than in males and OVX (2 (nd) Study). In these rats, a significant correlation between plasma phosphate and estrogen level was found. Sodium-dependent phosphate cotransporter (NaPiIIa) mRNA expression and protein abundance were higher in the renal cortex of younger male rats than in age- and weight-matched females. In adult rats, NaPiIIa mRNA and protein abundance were higher in OVX than in OVX+E, and in mature males as compared with age-matched females. These differences were not related to the parathyroid hormone (PTH) levels. Chronic estrogen administration was also associated with increased plasma calcium level and urinary calcium excretion. These results suggest that chronic estrogen treatment is associated with an inhibitory, PTH-independent effect on the expression of NaPiIIa in the kidney, leading to sex-related differences in phosphate balance.


Asunto(s)
Estrógenos/farmacología , Riñón/efectos de los fármacos , Riñón/metabolismo , Fosfatos/metabolismo , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo IIa/metabolismo , Envejecimiento/efectos de los fármacos , Envejecimiento/metabolismo , Animales , Estrógenos/administración & dosificación , Estrógenos/sangre , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Hormona Paratiroidea/metabolismo , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo IIa/genética , ATPasa Intercambiadora de Sodio-Potasio/genética , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
2.
Cell Mol Biol (Noisy-le-grand) ; 52(8): 78-86, 2006 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-17535740

RESUMEN

Cardiac steroids (CS) are specific inhibitors of Na+, K+-ATPase activity. Although the presence of CS-like compounds in animal tissues has been established, their physiological role is not clear. In a previous study we showed that in pulse-chase membrane-labeling experiments, long term (hours) interaction of CS at physiological concentrations (nM) with Na+, K+-ATPase, caused changes in endocytosed membrane traffic in human NT2 cells. This was associated with the accumulation of large vesicles adjacent to the nucleus. For this sequence of events to function in the physiological setting, however, CS would be expected to modify membrane traffic upon short term (min) exposure and membrane labeling. We now demonstrate that CS affects membrane traffic also following a short exposure. This was reflected by the CS-induced accumulation of FM1-43 and transferrin in the cells, as well as by changes in their colocalization with Na+, K+-ATPase. We also show that the CS-induced changes in membrane traffic following up to 2 hrs exposure are reversible, whereas longer treatment induces irreversible effects. Based on these observations, we propose that endogenous CS-like compounds are physiological regulators of the recycling of endocytosed membrane proteins and cargo in neuronal cells, and may affect basic mechanisms such as neurotransmitter release and reuptake.


Asunto(s)
Apoptosis/fisiología , Bufanólidos/metabolismo , Glicósidos Cardíacos/metabolismo , Digoxina/metabolismo , Ouabaína/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Apoptosis/efectos de los fármacos , Transporte Biológico Activo , Bufanólidos/farmacología , Glicósidos Cardíacos/farmacología , Línea Celular , Membrana Celular , Células Cultivadas , Digoxina/farmacología , Activación Enzimática , Humanos , Neuronas , Ouabaína/farmacología , Transducción de Señal , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores
3.
Biochim Biophys Acta ; 1325(1): 34-40, 1997 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-9106481

RESUMEN

Sodium-dependent phosphate entry into neuronal cells was demonstrated in synaptic plasma membrane vesicles and synaptosomes prepared from rat brains, in PC12 cells and in primary culture of pituitary cells. The extent of the sodium-dependent phosphate transport in the synaptic plasma membrane preparation, at [Na]out = 110 mM and [P(i)]out = 0.1 mM, varied between 0.28 to 1.02 nmol phosphate/mg membrane protein/min. In pituitary cells the value was only about 0.05 nmol P(i)/mg protein/min. In PC12 cells the activity increased from 0.0085 to 0.26 nmol P(i)/mg protein/min in the transit from undifferentiated to differentiated cells. The dependence of phosphate on sodium concentrations fits a model in which two sodium ions are required to transfer the phosphate into the cells with a K[Na]0.5 of 43 mM. The K(m) for the phosphate transport in the synaptic plasma membrane preparations was between 0.1 and 0.45 mM. It is concluded that sodium-driven active transport of phosphate is a ubiquitous activity in various types of neuronal cells.


Asunto(s)
Neuronas/metabolismo , Fosfatos/metabolismo , Sodio/farmacología , Vesículas Sinápticas/metabolismo , Sinaptosomas/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Encéfalo/citología , Encéfalo/metabolismo , Relación Dosis-Respuesta a Droga , Células PC12 , Hipófisis/citología , Hipófisis/metabolismo , Terminales Presinápticos/metabolismo , Ratas
4.
Biochim Biophys Acta ; 777(2): 323-30, 1984 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-6091758

RESUMEN

The antifibrillatory drug bretylium and the antiepileptic drug diphenylhydantoin cause an increase in the potential different and in the short-circuit current (SCC) across frog skin when added to the outer surface. The effect of both drugs depends upon the presence of sodium ions in the outer medium and is blocked by the specific sodium channel blocker, amiloride. Quantitative analysis shows that amiloride binds to open as well as closed mucosal sodium channel with the same affinity. The effects of diphenylhydantoin and bretylium differ with respect to their dependence on external pH. The diphenylhydantoin or the bretylium stimulatory effects are additive to the effects of oxytocin. In most cases the diphenylhydantoin and bretylium effects are also additive. It is concluded that the external side of the mucosal Na+ channels contains sites which interact specifically with either bretylium or diphenylhydantoin and thus remove the sodium induced closure of the channels.


Asunto(s)
Compuestos de Bretilio/farmacología , Tosilato de Bretilio/farmacología , Canales Iónicos/metabolismo , Fenitoína/farmacología , Piel/metabolismo , Sodio/metabolismo , Amilorida/farmacología , Animales , Interacciones Farmacológicas , Conductividad Eléctrica , Concentración de Iones de Hidrógeno , Canales Iónicos/efectos de los fármacos , Potenciales de la Membrana/efectos de los fármacos , Membrana Mucosa/metabolismo , Oxitocina/farmacología , Rana ridibunda , Sodio/farmacología
5.
Biochim Biophys Acta ; 693(2): 503-6, 1982 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-6297561

RESUMEN

Addition of the quanternary ammonium compound, bretylium, to the outer surface of a frog skin leads to an increase in the potential difference and in the short circuit current across the skin. Bretylium does not have any effect when applied to the inside face of the frog skin. The effect of bretylium is dependent upon the presence of sodium ions in the outer medium; it is depressed when sodium is replaced by choline or potassium but not when lithium substitutes for sodium. The bretylium effect is blocked by the specific sodium channel blocker, amiloride. It is proposed that bretylium opens mucosal, amiloride-sensitive sodium channels.


Asunto(s)
Amilorida/farmacología , Compuestos de Bretilio/farmacología , Tosilato de Bretilio/farmacología , Canales Iónicos/metabolismo , Pirazinas/farmacología , Piel/metabolismo , Sodio/metabolismo , Animales , Canales Iónicos/efectos de los fármacos , Potenciales de la Membrana/efectos de los fármacos , Membrana Mucosa/efectos de los fármacos , Membrana Mucosa/metabolismo , Rana pipiens
6.
Biochim Biophys Acta ; 1073(1): 65-8, 1991 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-1991148

RESUMEN

Digitalis-like compounds (DLC) were shown to be a normal constituent of the skin and plasma of toads. In order to assess the possible physiological role of these compounds in the toad, their levels were determined in the brain, plasma and skin following acclimation in different NaCl solutions. We demonstrate that an increase in salt concentrations in the animal medium from 0 to 1.2% decreased the levels of DLC in the brain by 50% without altering significantly its levels in the plasma and skin. An increase in medium salt concentration to 1.5% resulted in a 50% increase of DLC levels in the skin without changing its levels in the plasma or brain. These results suggest that skin and brain DLC may participate in the long-term salt and water homeostasis in the toad, while the plasma compound either participates in the short-term regulations of salt and water homeostasis or have some other, unknown, function.


Asunto(s)
Proteínas Sanguíneas/metabolismo , Encéfalo/metabolismo , Bufonidae/metabolismo , Digoxina , Saponinas , Piel/metabolismo , Equilibrio Hidroelectrolítico , Animales , Cardenólidos , Femenino , Homeostasis , Masculino , Ouabaína/antagonistas & inhibidores , Sales (Química)/metabolismo , Cloruro de Sodio/metabolismo
7.
Biochim Biophys Acta ; 817(1): 85-94, 1985 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-4005260

RESUMEN

86Rb(K+) transport across the plasma membrane of macrophage-like cells was studied. The cells used were the wild-type J774.2 and its two variants, CT2 cells, deficient in adenylate cyclase, and J7H1 cells, deficient in cAMP-dependent protein kinase. In the three cell lines about 15% of the total 86Rb(K+) influx is transported by the K+ carrier-mediated transport system. The 86Rb(K+) efflux carried by the same transporter is negligible when measured in the absence of ouabain in the medium. Therefore this carrier conducts a net inward flux of K+ under the experimental conditions used. The transporter is sensitive to extracellular Na+ and inhibited by 'loop' diuretics; bumetanide inhibits ouabain-resistant 86Rb(K+) influx with IC50 of 0.1, 5.0, and 0.05 microM for J774.2, CT2 and J7H1 macrophages, respectively. The membrane potential of the three cells was measured, using the distribution of [3H]tetraphenylphosphonium [( 3H]TPP+) across the plasma membrane, and found to be -80.1, -108.5 and -105.1 mV for J774.2, CT2 and J7H1 cells, respectively. The addition of bumetanide to the cell medium does not alter [3H]TPP+ uptake indicating that the transporter is electrically silent. It is concluded that despite the differences in cAMP metabolism by the three macrophages, the basic characteristics of K+ carrier-mediated transport system of the three cells are very similar.


Asunto(s)
Adenilil Ciclasas/deficiencia , Bumetanida/farmacología , Diuréticos/farmacología , Macrófagos/metabolismo , Ouabaína/farmacología , Potasio/metabolismo , Proteínas Quinasas/deficiencia , Animales , Transporte Biológico/efectos de los fármacos , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Variación Genética , Cinética , Ratones , Compuestos Onio/metabolismo , Compuestos Organofosforados/metabolismo , Rubidio/metabolismo , Sodio/farmacología
8.
Cardiovasc Res ; 20(3): 229-39, 1986 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3708656

RESUMEN

A ouabain like compound obtained from toad skin and plasma and identified to be a steroidal bufodienolide glycoside was found to displace ouabain from its binding site and to inhibit Na+-K+ ATPase, and have positive inotropic effects on cardiac muscle. The ionic and rate dependence of this positive inotropy was studied in the frog atrium. The effect was dependent on extracellular potassium, sodium, and calcium concentrations and on the rate of stimulation, which is similar to the properties of cardiac glycosides. Occasionally, the compound gave transient or even negative inotropic responses, as do the glycosides. The action potential configuration was also affected by the compound in the same complex pattern as is that of cardiac glycosides. It is concluded that the endogenous bufodienolide compound has the same physiological effects as cardiac glycosides. Since the same compound is present in toad plasma it may serve as an intrinsic humoral regulator of cardiac contractility. This study is the first detailed characterisation of the cardioactive properties of this compound.


Asunto(s)
Bufanólidos/farmacología , Glicósidos/farmacología , Corazón/efectos de los fármacos , Potenciales de Acción/efectos de los fármacos , Animales , Bufanólidos/aislamiento & purificación , Bufanólidos/metabolismo , Bufonidae , Glicósidos Cardíacos/metabolismo , Glicósidos/aislamiento & purificación , Glicósidos/metabolismo , Miocardio/metabolismo , Ouabaína/metabolismo , Rana ridibunda , Piel/análisis , Estimulación Química
9.
Hypertension ; 7(5): 729-33, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-2993163

RESUMEN

Material extracted and partially purified from plasma of the Sabra hypertension prone rats was found to be capable of 1) inhibiting the binding of 3H-ouabain to rat brain synaptosomes, 2) inhibiting the activity of rat brain microsomal Na, K activated adenosine triphosphatase, and 3) increasing the contractile force of rat heart muscle. The results demonstrate the presence of a ouabainlike compound in the plasma of these rats. The plasma concentration of this compound in Sabra hypertension prone rats was 698 +/- 199 nmol/ml in ouabain equivalents (SEM; n = 11) versus 2543 +/- 1140 nmol/ml (n = 9) in the Sabra normotensive strain. The presence of ouabainlike compound in the plasma is consistent with the hypothesis that this compound functions as a hormone that regulates Na, K activated adenosine triphosphatase activity and the physiological processes in which this enzyme is involved.


Asunto(s)
Hipertensión/sangre , Ouabaína/sangre , Animales , Cromatografía Líquida de Alta Presión , Masculino , Contracción Miocárdica/efectos de los fármacos , Ouabaína/farmacología , Ratas , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Tritio
10.
Neuropharmacology ; 26(10): 1541-4, 1987 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3683768

RESUMEN

The effect of ouabain and an endogenous ouabain-like compound (OLC) was studied on (3H)noradrenaline [3H)NA) release from rabbit pulmonary artery. Similarly to ouabain, OLC enhanced the release of (3H)NA in response to electrical stimulation. These findings are the first evidence that OLC is able to act presynaptically and enhance the amount of (3H)NA release per impulse. It is suggested that this mechanism might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.


Asunto(s)
Músculo Liso Vascular/metabolismo , Norepinefrina/metabolismo , Ouabaína/farmacología , Animales , Bufonidae , Cromatografía Líquida de Alta Presión , Femenino , Técnicas In Vitro , Masculino , Músculo Liso Vascular/efectos de los fármacos , Terminaciones Nerviosas/efectos de los fármacos , Terminaciones Nerviosas/metabolismo , Arteria Pulmonar/efectos de los fármacos , Arteria Pulmonar/metabolismo , Conejos
11.
Invest Ophthalmol Vis Sci ; 41(2): 482-7, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10670479

RESUMEN

PURPOSE: Tetraphenylphosphonium (TPP+) is a permeant lipophilic cation that accumulates in cultured cells and tissues as a function of the electrical membrane potential across the plasma membrane. This study was undertaken to determine whether TPP+ can be used for assessing membrane potential in intact lenses in organ culture. METHODS: Rat lenses were cultured in media containing 10 microM TPP+ and a tracer level of 3H-TPP+ for various times. 3H-TPP+ levels in whole lenses or dissected portions of lenses were determined by liquid scintillation counting. Ionophores, transport inhibitors, and neurotransmitters were also added to investigate their effects on TPP+ uptake. RESULTS. Incubation of lenses in low-K+ balanced salt solution and TC-199 medium, containing physiological concentrations of Na+ and K+, led to a biphasic accumulation of TPP+ in the lens that approached equilibrium by 12 to 16 hours of culture. The TPP+ equilibrated within 1 hour in the epithelium but penetrated more slowly into the fiber mass. The steady state level of TPP+ accumulation in the lens was depressed by 90% when the lenses were cultured in a medium containing high K+. The calculated membrane potential for the normal rat lens in TC-199 was -75 +/- 3 mV. Monensin (1 microM) and nigericin (1 microM), Na+H+ and K+H+ exchangers respectively, as well as the protonophore carbonylcyanide-m-chlorophenylhydrazone (CCCP, 10 microM) and the calcium ionophore A23187 (10 microM), abolished TPP+ accumulation and caused cloudiness of the lenses. The neurotransmitter acetylcholine at 50 microM decreased TPP+ accumulation in the lens, but this effect could be prevented by simultaneous application of 1 mM atropine. CONCLUSIONS: TPP+ accumulation can be used as an indicator of changes in membrane potential in intact lenses, but because of the long time required to reach steady state, its utility is limited. The slow accumulation of TPP+ and its slow efflux from the lens under conditions known to depolarize membranes are consistent with a diffusion barrier in the deep cortex and nucleus of the lens.


Asunto(s)
Indicadores y Reactivos/farmacocinética , Cristalino/fisiología , Compuestos Onio/farmacocinética , Compuestos Organofosforados/farmacocinética , Animales , Calcimicina/farmacología , Carbonil Cianuro m-Clorofenil Hidrazona/farmacología , Medios de Cultivo , Femenino , Cristalino/efectos de los fármacos , Masculino , Potenciales de la Membrana/fisiología , Monensina/farmacología , Monitoreo Fisiológico , Nigericina/farmacología , Técnicas de Cultivo de Órganos , Ratas , Ratas Sprague-Dawley
12.
Invest Ophthalmol Vis Sci ; 40(2): 407-13, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9950600

RESUMEN

PURPOSE: Fundamental to the maintenance of ionic concentration gradients and transparency of the lens is the activity of Na+,K+-adenosine triphosphatase (ATPase) in the epithelial layer. Recent studies have identified endogenous digitalis-like compounds (DLCs) and 19-norbufalin and its peptide derivatives in human cataractous lenses. These compounds inhibit the activity of Na+,K+-ATPase and have been suggested to be involved in cataract formation. The present experiments were designed to test this hypothesis by determining the ability of digitalis and DLCs to induce changes in protein composition and leakage from rat lenses in organ culture. METHODS: DLCs were determined in rat lenses using three independent assays: interaction with ouabain antibodies, interaction with bufalin antibodies, and inhibition of [3H]-ouabain binding to red blood cells. Rat lenses were incubated in modified TC-199 medium in 5% CO2 atmosphere at 37 degrees C for the time of the experiment. The onset of cataractogenesis was assessed by measuring protein leakage from lenses and by crystallin composition in the lens and media. RESULTS: DLCs were present in rat lens with concentrations 7 to 30 times higher in the capsular-epithelial layer than in the lens fibers regions. Ouabain, bufalin, digoxin, and DLC induced dose- and time-dependent leakage of protein from rat lenses. Lenses incubated with these compounds showed alterations in crystallin content consistent with changes that initiate opacity. All the compounds caused a multilayering of epithelial cells in the region surrounding the mitotic area and, at the same time, cell death in the central anterior region. CONCLUSIONS: Digitalis and endogenous DLCs are cataractogenic factors. These results, together with the demonstration of DLCs in the normal lens and their increased levels in human cataractous lenses, strongly suggest their involvement in the molecular mechanisms responsible for cataract formation.


Asunto(s)
Catarata/inducido químicamente , Cristalinas/metabolismo , Glicósidos Digitálicos/farmacología , Cristalino/efectos de los fármacos , Animales , Bufanólidos/inmunología , Bufanólidos/farmacología , Catarata/metabolismo , Catarata/patología , Relación Dosis-Respuesta a Droga , Electroforesis en Gel de Poliacrilamida , Inhibidores Enzimáticos/farmacología , Ensayo de Inmunoadsorción Enzimática , Femenino , Immunoblotting , Cristalino/metabolismo , Cristalino/patología , Masculino , Técnicas de Cultivo de Órganos , Ouabaína/inmunología , Ouabaína/farmacología , Ratas , Ratas Sprague-Dawley , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Factores de Tiempo
13.
J Endocrinol ; 128(1): 71-8, 1991 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1847965

RESUMEN

Two digitalis-like compounds (DLC) were purified to homogeneity from bovine plasma. The purification procedure consisted of organic extractions and batch chromatography followed by three subsequent separations using reverse-phase high-performance liquid chromatography. The presence of a DLC in the different fractions was monitored by their ability to inhibit (a) [3H]ouabain binding to rat brain synaptosomes, and (b) microsomal Na+/K(+)-ATPase activity. Using mass spectrometry and nuclear magnetic resonance spectroscopy the structure of one of the DLCs was identified as 11,13-dihydroxy-14-octadecaenoic acid. It is suggested that this new hydroxy, unsaturated, fatty acid derivative may regulate Na+/K(+)-ATPase activity under some physiological and pathological conditions.


Asunto(s)
Ácidos Oléicos/sangre , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Animales , Encéfalo/metabolismo , Bovinos , Cromatografía Líquida de Alta Presión , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Microsomas/efectos de los fármacos , Microsomas/enzimología , Ácidos Oléicos/química , Ouabaína/metabolismo , Unión Proteica/efectos de los fármacos
14.
J Neuroendocrinol ; 16(5): 458-63, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15117339

RESUMEN

Digitalis-like compounds (DLC) are steroidal hormones that are synthesized in, and released from, the adrenal gland, whose regulation may be directed by the hypothalamic-pituitary-adrenal (HPA) axis. Increasing evidence points to antitumour properties of these compounds and we hypothesized that the establishment of tumours in athymic nude mice may be facilitated by an abnormal synthesis or secretion of DLC. To explore this hypothesis, DLC concentrations were determined in the plasma, and in adrenal and hypothalamic tissues of nude compared to normal mice under basal conditions, and 30 min after a stress stimulus (i.p. injection of 100 micro l saline) with or without additional adrenocorticotropic hormone (ACTH) 1 micro g/per animal. Simultaneously, plasma corticosterone and serum adrenocorticotropic hormone (ACTH) concentrations were analysed. The basal DLC concentrations were similar in the plasma and the hypothalamus of both strains, whereas the basal adrenal DLC concentration was significantly lower in the nude mice compared to normal mice. The stress stimulus induced in normal mice a significant increase in DLC concentrations in the adrenal gland, the plasma and the hypothalamus. However, in nude mice, it caused an increase only in the adrenal gland and the hypothalamus, whereas the plasma DLC concentration was not affected. In both strains, the administration of ACTH in addition to injection stress did not provoke a further increase in DLC concentrations while inducing a significant increase in plasma corticosterone concentration. Regardless of the applied stimulus, the nude mice expressed significant lower DLC concentrations in the adrenal gland and the plasma compared to normal mice. The low basal adrenal DLC concentration in nude mice and their impaired DLC response towards stress- and ACTH stimulation both support an involvement of DLC in tumorigenesis.


Asunto(s)
Glándulas Suprarrenales/metabolismo , Glicósidos Cardíacos/sangre , Corticosterona/sangre , Hipotálamo/metabolismo , Estrés Fisiológico/sangre , Hormona Adrenocorticotrópica/sangre , Hormona Adrenocorticotrópica/fisiología , Animales , Glicósidos Digitálicos/sangre , Sistema Hipotálamo-Hipofisario/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Desnudos , Neuroinmunomodulación/fisiología , Sistema Hipófiso-Suprarrenal/metabolismo , Especificidad de la Especie , Estrés Fisiológico/fisiopatología
15.
Neurochem Int ; 7(4): 709-15, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-20492978

RESUMEN

Low concentrations (< 10(?7) M) of ouabain stimulate the activity of Na(+), K(+)-ATPase in whole homogenates of rat brain. The magnitude of this stimulation varies from 5 to 70%. The concentrations of ouabain which induces maximal stimulation is also highly variable and ranges between 10(?9) to 10(?7) M. The ouabain stimulation disappears following 1:50 dilution and 2 h preincubation or freezing and thawing of the membranes or their treatment with deoxycholate. "Aging" of a preparation of ATPase also results in loss of its ability to be stimulated by ouabain but ouabain inhibition is preserved. No stimulation of enzyme activity by ouabain is observed in rat brain microsomal fraction. The ?-adrenergic blocker propranolol does not inhibit the ouabain induced stimulation of ATPase activity. It is suggested that the stimulation of Na(+), K(+)-ATPase activity by low concentrations of cardiac glycosides if a result of either the displacement of an endogenous ouabain-like compound from the enzyme or an indirect effect by changing membrane surrounding environment of the Na(+), K(+)-ATPase.

16.
Hypertens Res ; 23 Suppl: S51-3, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11016820

RESUMEN

Na+,K+-ATPase activity in the epithelial layer is fundamental to the maintenance of ionic concentration gradients and transparency of the lens. Recently we have identified endogenous digitalislike compounds (DLC), 19-norbufalin and its peptide derivatives, in human cataractous lenses (Lichtstein et al. Eur J Biochem 216: 261-268, 1993). Lenses were treated with 10 nM ouabain, bufalin or 19-norbufalin derivative for 24 h and were compared to control lenses. Differential display analysis revealed that one of the down-regulated genes was 14-3-3 theta. Down-regulation was confirmed by Northern blot and by RT-PCR analysis. RT-PCR of additional 14-3-3 isoforms revealed that the eta and gamma isoforms of 14-3-3 are also down-regulated by ouabain, bufalin and 19-norbufalin derivative, whereas the zeta isoform is down-regulated only by bufalin. These results demonstrate that one of the consequences of Na+,K+-ATPase inhibition by exogenous or endogenous inhibitors is the down-regulation of mRNA transcripts encoding several isoforms of 14-3-3. Since the 14-3-3 proteins are multifunctional regulatory proteins, the reduction in the abundance of various isoforms will have profound effects on cell function. Furthermore, These results, together with the demonstration of digitalislike compounds in the normal lens, and their increased level in human cataractous lenses, strongly suggests their involvement in the molecular mechanisms responsible for cataract formation.


Asunto(s)
Cardiotónicos/farmacología , Digoxina , Cristalino/enzimología , Ouabaína/farmacología , Saponinas/farmacología , Transducción de Señal/fisiología , Tirosina 3-Monooxigenasa/genética , Proteínas 14-3-3 , Animales , Northern Blotting , Bufanólidos/farmacología , Cardenólidos , Cristalinas/genética , Expresión Génica/efectos de los fármacos , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , ATPasa Intercambiadora de Sodio-Potasio/metabolismo
17.
Neurosci Res ; 10(4): 235-44, 1991 May.
Artículo en Inglés | MEDLINE | ID: mdl-1652719

RESUMEN

The effect of a bufodienolide (monohydroxy-14,15-epoxy-20,22-dienolide glycoside) purified from toad skin was compared with that of ouabain on 3H-noradrenaline release and on the tension of rabbit pulmonary arterial strips. This compound exerted an ouabain-like activity. The neuronal effects of this bufodienolide derivative on squid axon were also studied and compared with those of ouabain. Both compounds enhanced the resting and stimulation-evoked (2 Hz, 360 shocks) release of 3H-noradrenaline. Moreover, in the presence of either this bufodienolide or ouabain, the tension of the rabbit artery increased gradually, and the contraction evoked by electrical stimulation was potentiated. Both compounds enhanced, in a prazosin-sensitive way, smooth muscle responses to noradrenaline and to electrical stimulation. In higher concentrations, they contracted smooth muscle cells of pulmonary artery, an action which was insensitive to prazosin. The bufodienolide was about 8 times more active in inhibition of 22Na efflux than was ouabain, but did not affect Ca efflux, which is not sensitive to ouabain. It is therefore concluded that compounds with an inhibitory effect on Na+,K(+)-ATPase are able to affect chemical neurotransmission of blood vessels in such a way that in lower concentrations they potentiate the release of noradrenaline, and in higher concentrations they contract directly the smooth muscle. These findings indicate that such compounds if they are present in the circulation might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.


Asunto(s)
Bufanólidos/farmacología , Glicósidos/farmacología , Músculo Liso Vascular/efectos de los fármacos , Neuronas/efectos de los fármacos , Ouabaína/farmacología , Animales , Axones/metabolismo , Decapodiformes , Técnicas In Vitro , Músculo Liso Vascular/metabolismo , Norepinefrina/metabolismo , Arteria Pulmonar/efectos de los fármacos , Arteria Pulmonar/metabolismo , Conejos , Sodio/metabolismo
18.
Brain Res ; 681(1-2): 75-83, 1995 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-7552294

RESUMEN

The binding of atrial natriuretic peptide (ANP) to rat olfactory bulb membranes and synaptosomes was examined. [125I]ANP (rat, 99-126) bound specifically to a single class of binding site on olfactory bulb membrane preparation with dissociation constant (Kd) of 106 pM and maximum binding capacity (Bmax) of 13.6 fmol/mg protein. Comparable results were obtained when the binding was characterized using displacement and kinetic experiments. The ring deleted analog of ANP, C-ANP (rat, 4-23) displaced [125I]ANP only minimally from its binding site in the membrane preparation. Saturation, displacement and blocking experiments on [125I]ANP binding to rat olfactory bulb synaptosomes revealed the presence of two distinct binding sites. Simultaneous analysis of homogeneous and heterogeneous displacement curves and blocking experiments revealed the quantitative characteristics of these receptors to be: Kd1 = 44 pM, Bmax1 = 42 fmol/mg protein and Kd2 = 1050 pM, Bmax2 = 173 fmol/mg protein, for the high and low affinity binding sites, respectively. Kinetic experiments further confirmed the differences between the receptors present in the membranes and the synaptosomes preparations. The demonstration of multiple ANP binding sites in olfactory bulb synaptosomes but not membrane preparations raises the possibility of a particular function of ANP in nerve terminals.


Asunto(s)
Bulbo Olfatorio/metabolismo , Receptores del Factor Natriurético Atrial/metabolismo , Sinaptosomas/metabolismo , Animales , Factor Natriurético Atrial/metabolismo , Sitios de Unión , Unión Competitiva/efectos de los fármacos , Técnicas In Vitro , Radioisótopos de Yodo , Cinética , Masculino , Membranas/metabolismo , Terminaciones Nerviosas/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Ratas
19.
Brain Res ; 682(1-2): 231-4, 1995 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-7552319

RESUMEN

Atrial natriuretic peptides (ANP) are a family of humoral compounds released from the heart atria and involved in water and salt homeostasis. ANP immunoreactivity and ANP-binding sites were also found in several areas of the central nervous system including the olfactory bulb. In the present study, the possible involvement of ANP in olfaction was tested by measuring the content and distribution of IR-ANP and ANP-binding sites in rat olfactory bulb in control and rats. The results implicate ANP in the processes leading to olfactory perception.


Asunto(s)
Factor Natriurético Atrial/fisiología , Olfato/fisiología , Animales , Autorradiografía , Radioisótopos de Yodo , Bulbo Olfatorio/fisiología , Radioinmunoensayo , Ratas
20.
Brain Res ; 325(1-2): 13-9, 1985 Jan 28.
Artículo en Inglés | MEDLINE | ID: mdl-2858247

RESUMEN

Material extracted and partially purified from human cerebrospinal fluid (CSF) is capable of: a, inhibiting [3H]ouabain binding to rat brain synaptosomes; b, inhibiting the activity of purified pig kidney Na+,K+-ATPase; and c, inhibiting ouabain sensitive induced 86Rb influx to tissue cultured fibroblasts. These results demonstrate the existence of an 'ouabain like' compound (OLC) in human CSF, and are consistent with the hypothesis of the function of this compound as a neuromodulator.


Asunto(s)
Ouabaína/líquido cefalorraquídeo , Sitios de Unión , Encéfalo/metabolismo , Fibroblastos/metabolismo , Humanos , Neurotransmisores , Ouabaína/farmacología , Ouabaína/fisiología , Rubidio/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Sinaptosomas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA